Search Results - "Colin, Céline"

Trends in virological and clinical outcomes in individuals with HIV-1 infection and virological failure of drugs from three antiretroviral drug classes: a cohort study by Costagliola, Dominique, Lodwick, Rebecca, Ledergerber, Bruno, Torti, Carlo, van Sighem, Ard, Podzamczer, Daniel, Mocroft, Amanda, Dorrucci, Maria, Masquelier, Bernard, de Luca, Andrea, Jansen, Klaus, De Wit, Stephane, Obel, Niels, Fätkenheuer, Gerd, Touoloumi, Giota, Mussini, Cristina, Castagna, Antonella, Stephan, Cristoph, García, Federico, Zangerle, Robert, Duval, Xavier, Pérez-Hoyos, Santiago, Meyer, Laurence, Ghosn, Jade, Fabre-Colin, Céline, Kjaer, Jesper, Chene, Genevieve, Grarup, Jesper, Phillips, Andrew

“…Summary Background Limited treatment options have been available for people with HIV who have had virological failure of the three original classes of HIV…”
Get full text

The Incidence of AIDS-Defining Illnesses at a Current CD4 Count ≥200 Cells/µL in the Post–Combination Antiretroviral Therapy Era by Mocroft, A., Furrer, H. J., Miro, J. M., Reiss, P., Mussini, C., Kirk, O., Abgrall, S., Ayayi, S., Bartmeyer, B., Braun, D., Castagna, A., d'Arminio Monforte, A., Gazzard, B., Gutierrez, F., Hurtado, I., Jansen, K., Meyer, L., Muñoz, P., Obel, N., Soler-Palacin, P., Papadopoulos, A., Raffi, F., Ramos, J. T., Rockstroh, J. K., Salmon, D., Torti, C., Warszawski, J., de Wit, S., Zangerle, R., Fabre-Colin, C., Kjaer, J., Chene, G., Grarup, J., Lundgren, J. D., Mocroft, Amanda, Furrer, Hansjakob, Miro, Jose M., Reiss, Peter, Mussini, Cristina, Kirk, Ole, Abgrall, Sophie, Ayayi, Sylvie, Bartmeyer, Barbara, Braun, Dominique, Castagna, Antonella, d'Arminio Monforte, Antonella, Gazzard, Brian, Gutierrez, Félix, Hurtado, Isabel, Jansen, Klaus, Meyer, Laurence, Muñoz, Pepa, Obel, Niels, Soler-Palacin, Pere, Papadopoulos, Antonios, Raffi, François, Ramos, Jose T., Rockstroh, Jürgen, Salmon, Dominique, Torti, Carlo, Warszawski, Josianne, de Wit, Stephane, Zangerle, Robert, Fabre-Colin, Céline, Kjaer, Jesper, Chene, Genevieve, Grarup, Jesper, Lundgren, Jens D., Lundgren, Jens, Miiro, Jose, Palacin, Pere Soler, Torti, Carolo, Warszawski, Josiane, Rockstroh, Jurgen, Ramos, José, Miró, Jose M., Munoz, Pepa, Judd, Ali, Haerry, David, Weller, Ian, Casabona, Jordi, Costagliola, Dominique, d'Arminio-Monforte, Antonella, Battegay, Manuel, Prins, Maria, de Wolf, Frank, Colin, Céline, Schwimmer, Christine, Touzeau, Guillaume, Campbell, Maria, Bohlius, Julia, Bouteloup, Vincent, Bucher, Heiner, Cozzi-Lepri, Alessandro, Dabis, François, Dorrucci, Maria, Egger, Matthias, Engsig, Frederik, Lambotte, Olivier, Lewden, Charlotte

“…Few studies consider the incidence of individual AIDS-defining illnesses (ADIs) at higher CD4 counts, relevant on a population level for monitoring and…”
Get full text

Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a European multicohort study by Wittkop, Linda, Dr, Günthard, Huldrych F, Prof, de Wolf, Frank, Prof, Dunn, David, PhD, Cozzi-Lepri, Alessandro, PhD, de Luca, Andrea, MD, Kücherer, Claudia, PhD, Obel, Niels, MD, von Wyl, Viktor, PhD, Masquelier, Bernard, PharmD, Stephan, Christoph, MD, Torti, Carlo, MD, Antinori, Andrea, MD, García, Federico, PhD, Judd, Ali, PhD, Porter, Kholoud, PhD, Thiébaut, Rodolphe, MD, Castro, Hannah, MSc, van Sighem, Ard I, PhD, Colin, Céline, Kjaer, Jesper, MSc, Lundgren, Jens D, Prof, Paredes, Roger, MD, Pozniak, Anton, MD, Clotet, Bonaventura, MD, Phillips, Andrew, Prof, Pillay, Deenan, Prof, Chêne, Geneviève, Prof

“…Summary Background The effect of transmitted drug resistance (TDR) on first-line combination antiretroviral therapy (cART) for HIV-1 needs further study to…”
Get full text

Safety and immunogenicity of the live attenuated intranasal pertussis vaccine BPZE1: a phase 1b, double-blind, randomised, placebo-controlled dose-escalation study by Jahnmatz, Maja, Richert, Laura, al-Tawil, Nabil, Storsaeter, Jann, Colin, Céline, Bauduin, Claire, Thalen, Marcel, Solovay, Ken, Rubin, Keith, Mielcarek, Nathalie, Thorstensson, Rigmor, Locht, Camille, Dager, Lena, Ekholm, Nina, Gustafsson, Margareta, Linde, Åsa, Lång, Cecilia, Nastase, Maria, Reinholdsson, Inga-Lill, Sigurdardottir, Erla, Wahlberg, Anneli, Zarea, Izabella, Aktas, Teodora, Andersson, Ingrid, Hanson Pihlainen, Eva, Ljungman, Margaretha, Ringman, Maj, Tecleab, Teghesti, Wehlin, Lena, Allais, Florence, Assuied, Alex, Chêne, Geneviève, Gilbert, Camille, Jean, Delphine, Le Marec, Fabien, Moinot, Laetitia, Reboud, Philippe, Rousseau, Emilie, Roy, Céline, Schwimmer, Christine, Taïeb, Ludivine, Wallet, Cédrick, Derocle, Gabrielle, Gueguen, Sonia, Lévy-Marchal, Claire, Esperou, Hélène, Debrie, Anne-Sophie, Raze, Dominique, Coutte, Loïc, Diallo, Alpha, Mercier, Noémie

“…Long-term protection and herd immunity induced by existing pertussis vaccines are imperfect, and a need therefore exists to develop new pertussis vaccines…”
Get full text

Long-Term Efficacy and Safety of Raltegravir, Etravirine, and Darunavir/Ritonavir in Treatment-Experienced Patients: Week 96 Results From the ANRS 139 TRIO Trial by Fagard, Catherine, Colin, Céline, Charpentier, Charlotte, Rami, Agathe, Jacomet, Christine, Yeni, Patrick, Vittecoq, Daniel, Katlama, Christine, Molina, Jean-Michel, Descamps, Diane, Chêne, Geneviève, Yazdanpanah, Yazdan

“…Among 103 patients with multidrug-resistant HIV who initiated raltegravir, etravirine, and darunavir/ritonavir-containing regimen in the ANRS 139 TRIO trial,…”
Get full text

Severe morbidity according to sex in the era of combined antiretroviral therapy: the ANRS CO3 Aquitaine Cohort by Hessamfar, Mojgan, Colin, Céline, Bruyand, Mathias, Decoin, Madeleine, Bonnet, Fabrice, Mercié, Patrick, Neau, Didier, Cazanave, Charles, Pellegrin, Jean-Luc, Dabis, François, Morlat, Philippe, Chêne, Geneviève

“…To describe trends and determinants of severe morbidity in HIV-infected women and men. A French prospective cohort of HIV-infected patients of both sexes and…”
Get full text

Continuous versus intermittent treatment strategies during primary HIV-1 infection: the randomized ANRS INTERPRIM Trial by GOUJARD, Cécile, EMILIE, Dominique, CHAIX, Marie-Laure, GALANAUD, Pierre, CHENE, Genevieve, ROUSSILLON, Caroline, GODOT, Veronique, ROUZIOUX, Christine, VENET, Alain, COLIN, Céline, PIALOUX, Gilles, GIRARD, Pierre-Marie, BOILET, Valérie

“…The ANRS-112 INTERPRIM trial assessed whether fixed-cycles of antiretroviral treatment interruption (ART-STI) combined or not with pegylated interferon…”
Get full text

Role of baseline HIV-1 DNA level in highly-experienced patients receiving raltegravir, etravirine and darunavir/ritonavir regimen (ANRS139 TRIO trial) by Charpentier, Charlotte, Fagard, Catherine, Colin, Céline, Katlama, Christine, Molina, Jean-Michel, Jacomet, Christine, Visseaux, Benoit, Taburet, Anne-Marie, Brun-Vézinet, Françoise, Chêne, Geneviève, Yazdanpanah, Yazdan, Descamps, Diane

“…In the ANRS 139 TRIO trial, the use of 3 new active drugs (raltegravir, etravirine, and darunavir/ritonavir), resulted in a potent and sustained inhibition of…”
Get full text

Risk factors and outcomes for late presentation for HIV-positive persons in Europe: results from the Collaboration of Observational HIV Epidemiological Research Europe Study (COHERE) by Mocroft, Amanda, Lundgren, Jens D, Sabin, Miriam Lewis, Monforte, Antonella d'Arminio, Brockmeyer, Norbert, Casabona, Jordi, Castagna, Antonella, Costagliola, Dominique, Dabis, Francois, De Wit, Stéphane, Fätkenheuer, Gerd, Furrer, Hansjakob, Johnson, Anne M, Lazanas, Marios K, Leport, Catherine, Moreno, Santiago, Obel, Niels, Post, Frank A, Reekie, Joanne, Reiss, Peter, Sabin, Caroline, Skaletz-Rorowski, Adriane, Suarez-Lozano, Ignacio, Torti, Carlo, Warszawski, Josiane, Zangerle, Robert, Fabre-Colin, Céline, Kjaer, Jesper, Chene, Genevieve, Grarup, Jesper, Kirk, Ole

“…Few studies have monitored late presentation (LP) of HIV infection over the European continent, including Eastern Europe. Study objectives were to explore the…”
Get full text

Stimulation of the primary anti-HIV antibody response by IFN-α in patients with acute HIV-1 infection by Adalid‐Peralta, Laura, Godot, Véronique, Colin, Céline, Krzysiek, Roman, Tran, Thi, Poignard, Pascal, Venet, Alain, Hosmalin, Anne, Lebon, Pierre, Rouzioux, Christine, Chene, Genevieve, Emilie, Dominique

“…Type I IFNs are needed for the production of antiviral antibodies in mice; whether they also stimulate primary antibody responses in vivo during human viral…”
Get full text

Pharmacokinetics of etravirine, raltegravir and darunavir/ritonavir in treatment experienced patients by BARRAIL-TRAN, Aurélie, YAZDANPANAH, Yazdan, FAGARC, Catherine, TABURET, Anne-Marie, GOLDWIRT, Lauriane, CHENE, Geneviève, COLIN, Céline, PIKETTY, Christophe, BOLLENS, Diane, KATLAMA, Christine, DESCAMPS, Diane, MOLINA, Jean-Michel

“…Etravirine is an enzyme inducer and could lower the concentration of combined drugs. Ten HIV-1-infected patients with multiple treatment failure received…”
Get full text

Resistance analyses in highly experienced patients failing raltegravir, etravirine and darunavir/ ritonavir regimen by CHARPENTIER, Charlotte, ROQUEBERT, Bénédicte, YAZDANPANAH, Yazdan, DESCAMPS, Diane, COLIN, Céline, TABURET, Anne-Marie, FAGARD, Catherine, KATLAMA, Christine, MOLINA, Jean-Michel, JACOMET, Christine, BRUN-VEZINET, Françoise, CHENE, Geneviève

“…ANRS 139 TRIO trial was a phase II noncomparative trial that evaluated in highly experienced patients, a combination of raltegravir, etravirine and darunavir…”
Get full text

Reply to comment on ‘pharmacokinetics of etravirine, raltegravir and darunavir/ritonavir in treatment experienced patients’ by Barrail-Tran, Aurélie, Yazdanpanah, Yazdan, Goldwirt, Lauriane, Chêne, Geneviève, Colin, Céline, Piketty, Christophe, Bollens, Diane, Katlama, Christine, Descamps, Diane, Molina, Jean-Michel, Fagard, Catherine, Taburet, Anne-Marie

Get full text

Is It Safe to Discontinue Primary Pneumocystis jiroveci Pneumonia Prophylaxis in Patients with Virologically Suppressed HIV Infection and a CD4 Cell Count <200 Cells/μL? by The Opportunistic Infections Project Team of the Collaboration of Observational HIV Epidemiological Research in Europe (COHERE)

“…Background. Current guidelines suggest that primary prophylaxis for Pneumocystis jiroveci pneumonia (PcP) can be safely stopped in human immunodeficiency virus…”
Get full text

Triple-class virologic failure in HIV-infected patients undergoing antiretroviral therapy for up to 10 years by Lodwick, Rebecca, Costagliola, Dominique, Reiss, Peter, Torti, Carlo, Teira, Ramón, Dorrucci, Maria, Ledergerber, Bruno, Mocroft, Amanda, Podzamczer, Daniel, Cozzi-Lepri, Alessandro, Obel, Niels, Masquelier, Bernard, Staszewski, Schlomo, García, Federico, De Wit, Stephane, Castagna, Antonella, Antinori, Andrea, Judd, Ali, Ghosn, Jade, Touloumi, Giota, Mussini, Cristina, Duval, Xavier, Ramos, José, Meyer, Laurence, Warsawski, Josiane, Thorne, Claire, Masip, Joan, Pérez-Hoyos, Santiago, Pillay, Deenan, van Sighem, Ard, Lo Caputo, Sergio, Günthard, Huldrych, Paredes, Roger, De Luca, Andrea, Paraskevis, Dimitrios, Fabre-Colin, Céline, Kjaer, Jesper, Chêne, Genèvieve, Lundgren, Jens D, Phillips, Andrew N

“…Life expectancy of people with human immunodeficiency virus (HIV) is now estimated to approach that of the general population in some successfully treated…”
Get more information

Immunity, inflammation and reservoir in patients at an early stage of HIV infection on intermittent ART (ANRS 141 TIPI Trial) by Piroth, Lionel, Moinot, Laetitia, Yeni, Patrick, Avettand-Fénoel, Véronique, Reynes, Jacques, Girard, Pierre-Marie, Marchou, Bruno, Georget, Aurore, Rouzioux, Christine, Autran, Brigitte, Duvillard, Laurence, Chêne, Geneviève, Fagard, Catherine

“…The objective of this study was to assess clinical and biological changes during intermittent ART (I-ART) started early, with significant time spent on versus…”
Get full text

Predictors of CD4+T-Cell Counts of HIV Type 1—Infected Persons After Virologic Failure of All 3 Original Antiretroviral Drug Classes by Costagliola, Dominique, Ledergerber, Bruno, Torti, Carlo, van Sighem, Ard, Podzamczer, Daniel, Mocroft, Amanda, Dorrucci, Maria, Masquelier, Bernard, de Luca, Andrea, Jansen, Klaus, De Wit, Stephane, Obel, Niels, Fätkenheuer, Gerd, Touloumi, Giota, Mussini, Cristina, Castagna, Antonella, Stephan, Cristoph, García, Federico, Zangerle, Robert, Duval, Xavier, Perez-Hoyos, Santiago, Meyer, Laurence, Ghosn, Jade, Fabre-Colin, Céline, Kjaer, Jesper, Chêne, Genevieve, Grarup, Jesper, Phillips, Andrew, Lodwick, Rebecca, Günthard, Huldrych F, Michalik, Claudia, Chrysos, George

“…Background. Low CD4 + T-cell counts are the main factor leading to clinical progression in human immunodeficiency virus type 1 (HIV-1) infection. We aimed to…”
Get full text

Risk Factors and Outcomes for Late Presentation for HIV-Positive Persons in Europe: Results from the Collaboration of Observational HIV Epidemiological Research Europe Study (COHERE): e1001510 by Mocroft, Amanda, Lundgren, Jens D, Sabin, Miriam Lewis, Monforte, Arminio, Brockmeyer, Norbert, Casabona, Jordi, Castagna, Antonella, Costagliola, Dominique, Dabis, Francois, Wit, Stéphane De, Fätkenheuer, Gerd, Furrer, Hansjakob, Johnson, Anne M, Lazanas, Marios K, Leport, Catherine, Moreno, Santiago, Obel, Niels, Post, Frank A, Reekie, Joanne, Reiss, Peter, Sabin, Caroline, Skaletz-Rorowski, Adriane, Suarez-Lozano, Ignacio, Torti, Carlo, Warszawski, Josiane, Zangerle, Robert, Fabre-Colin, Céline, Kjaer, Jesper, Chene, Genevieve, Grarup, Jesper, Kirk, Ole, EuroCoord, study in

“…Background Few studies have monitored late presentation (LP) of HIV infection over the European continent, including Eastern Europe. Study objectives were to…”
Get full text

Calendar Time Trends in the Incidence and Prevalence of Triple-Class Virologic Failure in Antiretroviral Drug-Experienced People With HIV in Europe by Nakagawa, Fumiyo, Lodwick, Rebecca, Costagliola, Dominique, van Sighem, Ard, Torti, Carlo, Podzamczer, Daniel, Mocroft, Amanda, Ledergerber, Bruno, Dorrucci, Maria, Cozzi-Lepri, Alessandra, Jansen, Klaus, Masquelier, Bernard, García, Federico, De Wit, Stephane, Stephan, Christoph, Obel, Niels, Fätkenhaeuer, Gerd, Castagna, Antonella, Sambatakou, Helen, Mussini, Cristina, Ghosn, Jade, Zangerle, Robert, Duval, Xavier, Meyer, Laurence, Perez-Hoyos, Santiago, Fabre Colin, Céline, Kjaer, Jesper, Chene, Genevieve, Grarup, Jesper, Phillips, Andrew

“…Despite the increasing success of antiretroviral therapy (ART), virologic failure of the 3 original classes [triple-class virologic failure, (TCVF)] still…”
Get full text

Stimulation of the primary anti-HIV antibody response by IFN-{alpha} in patients with acute HIV-1 infection by Adalid-Peralta, Laura, Godot, Véronique, Colin, Céline, Krzysiek, Roman, Tran, Thi, Poignard, Pascal, Venet, Alain, Hosmalin, Anne, Lebon, Pierre, Rouzioux, Christine, Chêne, Geneviève, Emilie, Dominique, The Interprim Anrs 112 Study Group

“…Type I IFNs are needed for the production of antiviral antibodies in mice; whether they also stimulate primary antibody responses in vivo during human viral…”
Get full text